208 related articles for article (PubMed ID: 35698056)
1. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
[TBL] [Abstract][Full Text] [Related]
2. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
3. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Macular Pigment Optical Density in Healthy Eyes Based on Dual-Wavelength Autofluorescence Imaging in South Indian Population.
Srinivasan R; Teussink MM; Sloan KR; Surya J; Raman R
Transl Vis Sci Technol; 2020 Jul; 9(8):40. PubMed ID: 32855886
[TBL] [Abstract][Full Text] [Related]
5. Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.
Müller S; Heeren TFC; Bonelli R; Fruttiger M; Charbel Issa P; Egan CA; Holz FG
Br J Ophthalmol; 2019 Mar; 103(3):398-403. PubMed ID: 29858186
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
[TBL] [Abstract][Full Text] [Related]
7. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
8. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
[TBL] [Abstract][Full Text] [Related]
9. Comparison of macular pigment in three types of macular telangiectasia.
Sawa M; Gomi F; Ueno C; Suzuki M; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):689-96. PubMed ID: 22790309
[TBL] [Abstract][Full Text] [Related]
10. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
11. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
12. Lower Macular Pigment Optical Density in Foveal-Involved Glaucoma.
Siah WF; Loughman J; O'Brien C
Ophthalmology; 2015 Oct; 122(10):2029-37. PubMed ID: 26249732
[TBL] [Abstract][Full Text] [Related]
13. Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2.
Heeren TFC; Tzaridis S; Bonelli R; Pfau M; Fruttiger M; Okada M; Egan C; Charbel Issa P; Holz FG
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1760-1767. PubMed ID: 31022297
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
Park YG; Park YH
PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
[TBL] [Abstract][Full Text] [Related]
15. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
[TBL] [Abstract][Full Text] [Related]
16. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
17. Macular Pigment Optical Density Fluctuation as a Function of Pupillary Mydriasis: Methodological Considerations for Dual-Wavelength Autofluorescence.
Loskutova E; Butler JS; Hernandez Martinez G; Flitcroft I; Loughman J
Curr Eye Res; 2021 Apr; 46(4):532-538. PubMed ID: 32842779
[TBL] [Abstract][Full Text] [Related]
18. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
19. The Spatial Profile of Macular Pigments Is Related to the Topological Characteristics of the Foveal Avascular Zone.
Balaratnasingam C; Chae B; Remmer MH; Gomez E; Suzuki M; Engelbert M; Spaide RF
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7859-65. PubMed ID: 26658507
[TBL] [Abstract][Full Text] [Related]
20. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
